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3Abstract
This doctoral thesis describes the development of novel miniaturized analytical tools applicable to
in situ nanoscale studies for a deeper understanding of biomolecular interactions. Capillary
electrophoresis (CE), atomic force microscopy (AFM), quartz crystal microbalance (QCM)
measurements, and partial filling affinity capillary electrophoresis (PF-ACE) were utilized to study
the separation of lipoproteins and their interactions with extracellular matrix (ECM) components.
The major focus of the study was on low and high density lipoprotein particles (LDL and HDL),
which are the main vehicles of cholesterol transport in human circulation. Lipoproteins are
involved in specific interactions with proteoglycans (PGs) and collagens, structural components
of ECM of the arterial wall. The interactions lead to the development and progression of
atherosclerosis and diabetes.
The first step of the work was to clarify, by AFM, the structural and molecular properties of
collagens I and III under physiological conditions. Study was made of the effect of decorin on the
fibril  formation  of  collagen,  which  promotes  and  enhances  the  binding  of  collagen  with  LDL.
Moreover, the immobilized collagen I surface was exposed to in situ glycation, and the adsorption
pattern of the glycated collagen was elucidated. In addition to AFM, QCM was used to examine
characteristics of the interaction between collagens and apolipoprotein B-100 (apoB-100), the
major protein of LDL. Values of the dissociation constant were then estimated by evaluating the
differences in strength of the binding process.
To avoid strong and unwanted adsorption of lipoprotein particles on the inner wall of the capillary,
the effect of five different sugars on the separation of lipoproteins was studied by CE in uncoated
capillary at physiological pH 7.4. In addition, the effect of the sugars on the size of the lipoproteins
was elucidated by asymmetrical flow field-flow fractionation (AsFlFFF) and dynamic light
scattering (DLS) measurements. Molecular dynamics (MD) simulations were employed to
discover the influence of sugars on the structures of apolipoprotein E (apoE) of HDL and apoB-
100 of LDL.
4In another attempt to eliminate the adsorption of positive analytes and allow their separation, a
polycationic coating was developed and covalently bound to the inner wall of the fused silica
capillary. The immobilization of the coating was achieved in a three-step procedure during on-line
polymerization. The stability study of the coating in wide pH range 3–8 demonstrated the
suitability of the coating for the separation of small proteins and b-blockers.
Finally, PF-ACE technique was used to evaluate in detail the interactions involved in the binding
of the most common isoforms of apoE with the major glycosaminoglycan (GAG) chain of PGs,
viz.,  chondroitin-6-sulfate  (C6S).  As  is  well  known,  PF-ACE enables  the  evaluation  of  affinity
constants only for single-type interactions, and adsorption energy distribution (AED) calculations
were introduced to widen its application. AED allowed characterization of the heterogeneity of
interactions and permitted evaluation of differences in the binding process strengths.
The key contributions of the work are the promising and reliable tools developed for separation
and interaction studies of biological processes occurring in the ECM.
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ACE affinity capillary electrophoresis
AED adsorption energy distribution
AFM atomic force microscopy
AGEs advanced glycation end products
apoB-100 apolipoprotein B-100
apoE apolipoprotein E
Arg arginine
AsFlFFF asymmetrical flow field-flow fractionation
ATRP atom transfer radical polymerization
BGE background electrolyte solution
BSA bovine serum albumin
C6S chondroitin-6-sulfate
CE capillary electrophoresis
CEC capillary electrochromatography
CET capillary electromigration techniques
Cys cysteine
DIEA N,N-diisopropylethylamine
DMF N,N-dimethylformamide
DLS dynamic light scattering
DS dermatan sulfate
ECM extracellular matrix
EDTA ethylenediaminetetraacetic acid
EOF electroosmotic flow
Fmoc 9-fluorenylmethoxycarbonyl
FWHM full width at half maximum
GAG glycosaminoglycan
HCTU O-(6-chlorobenzotriazol-1-yl)-N,N,N´,N´-tetramethyluronium
hexafluorophosphate
HDL high density lipoprotein
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HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
IDL intermediate density lipoprotein
LDL low density lipoprotein
MD molecular dynamics
MOTAC 2-(methacryloyl)oxyethyl]trimethylammonium chloride
NMM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 4-methylmorpholine
OT-CEC open-tubular capillary electrochromatography
P2VP-b-PEO poly(2-vinylpyridine)-block-(ethylene oxide)
P2QVP-b-PEO poly(2-vinylpyridine)-block-poly(ethylene oxide)
PF-ACE partial filling affinity capillary electrophoresis
PMOTAC poly[2-(methacryloyl)oxyethyl]trimethylammonium chloride
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QCM quartz crystal microbalance
RH relative humidity
SEM scanning electron microscopy
SI-ATRP surface initiated atom transfer radical polymerization
SPR surface plasmon resonance
TFA trifluoroacetic acid
THF tetrahydrofuran
TIS triisopropylsilane
VLDL very low density lipoprotein
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Symbols
ܥ concentration [ ௠௢௟
௅
 ]
ܥ௠௔௫ highest concentration of analyte [
௠௢௟
௅
 ]
ܥ௠௜௡ lowest concentration of analyte [
௠௢௟
௅
 ]
ܥோ concentration of receptor zone in the capillary [
௠௢௟
௅
 ]
݂(݈݊ܭ) adsorption energy distribution
I ionic strength
ܭ௔ affinity constant or association equilibrium constant [
௅
௠௢௟
 ]
ܭ௔,௜ association equilibrium constant for site i [ ௅௠௢௟ ]
ܭௗ dissociation constant [
௠௢௟
௅
 ]
ܭ௠௔௫
଴.ଵ
஼೘ೌೣ
 [ ௅
௠௢௟
 ]
ܭ௠௜௡
ଵ଴
஼೘೔೙
 [ ௅
௠௢௟
 ]
݇௢௙௙ dissociation rate constant [s-1]
݇௢௡ association rate constant [
௅
௠௢௟	௦
 ]
ܮௗ௘௧ length to detector [m]
ܮ௧௢௧ total length [m]
r inner radius of the capillary [m]
߆௕ bound molar fraction of analyte
߆௙ free molar fraction of analyte
߆௠௔௫,௜ monolayer saturation capacity
߆(ܥ,ܭ) local adsorption isotherm model
T temperature [K]
V separation voltage [V]
௔ܸ௣௣ apparent volume of receptor zone in the capillary [
௅
௏	௦
 ]
௙ܸ௜௟௟௜௡௚ injected volume of receptor zone [L]
ோܸ real volume of receptor zone in the capillary [L]
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ߤ஺ average mobility of analyte–receptor complex [ ௠
మ
௏	௦
 ]
ߤ௕ mobility of bound molar fraction of analyte [
௠మ
௏	௦
 ]
ߤ௙ mobility of free molar fraction of analyte [
௠మ
௏	௦
 ]
ߤ௧௢௧ total mobility of charged analyte [
௠మ
௏	௦
 ]
ߤ௘௢ electroosmotic mobility [
௠మ
௏	௦
 ]
ߤ௘௣ electrophoretic mobility [
௠మ
௏	௦
 ]
ݐ଴,ௗ௘௧ time needed for analyte to reach the detector in the absence of receptor [s]
ݐ௙௜௟௟௜௡௚ filling time [s]
ݐ௠ migration time of the analyte [s]
ݐ௧௢௧௔௟ time required for receptor to reach the detector under pressure [s]
߂ݐ௙௜௟௟௜௡௚ change in filling time [s]
߂ݐ௠ change in migration time [s]
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1 Introduction
Instrumental analytical and bioanalytical techniques and systems have become an essential area of
research and development for the information they can provide about chemical, physical,
biological and environmental phenomena and biological interactions. Microsystems and
miniaturized instrumental techniques, which can be considered key technologies for future
progress in biochemistry, biotechnology, and medicine, have inspired many scientists toward
further methodological developments. Nevertheless, there continues to be a great need for
analytical systems that enable dynamic and real-time monitoring of biological processes.
Atherosclerosis and diabetes are major contributors to morbidity and mortality in industrialized
countries [1-4]. Researchers are increasingly focusing on the mechanics responsible for these lethal
diseases, examining the structural modification of lipoprotein particles and their entrapment in the
ECM  of  the  inner  layer  of  arterial  wall  as  key  factors  in  the  onset  and  development  of
atherosclerotic plaque. Over the years, numerous analytical techniques have been applied to
evaluate the accumulation and modification processes occurring in human arteries.
Capillary electromigration techniques (CET) have been successfully adapted in an impressive
number  of  areas  at  the  forefront  of  biochemical  research.  The  goal  of  CET is  to  overcome the
technological limitations of other methodologies, still employed in many laboratories, for the study
of compounds of small molecular masses and larger biomolecules. CET has many advantages over
traditional techniques, including high separation selectivity, small sample-size, high-speed
analysis, high separation efficiency, versatility, robustness, excellent mass sensitivity, and low
reagent consumption. Further, CET can easily be implemented to micro-fabricated microchannel
structures, and miniaturized and microchip-based electromigration techniques have been rapidly
developed. In addition to CET, AFM and QCM techniques have great potential in biochemical
research. AFM provides images on the nanometer scale by making use of a highly sensitive and
tiny probe that is essentially pulled across a surface coated with biological material. Topographical
images can be obtained down to nanometer scale under ambient or physiological conditions. In
QCM, biomolecules can be directly immobilized on specific sensor chips, which allows
17
sophisticated studies of interactions with particular analytes. Both AFM and QCM can supply
insight into the binding properties of biological systems.
The objectives of this doctoral study were to develop new miniaturized instrumental techniques
applicable to in situ nanoscale studies, and other experimental and computational techniques, to
enhance our understanding of molecular interactions relevant to atherogenesis and diabetes.
Several CET, AFM, and QCM were selected as the techniques of choice, while AsFlFFF, MD
simulations, DLS, and AED calculations were applied as complementary and supportive tools.
The specific aims of my research were the following:
- to  study  collagen  fibrillogenesis  and  the  ability  of  collagen  to  bind  decorin  on  different
substrates, and the influence of decorin on the adsorption patterns of collagens recorded by
AFM (Paper I)
- utilizing QCM, to clarify the interaction between collagen coatings and apoB-100, and to
estimate the dissociation constants for the interactions (Paper I)
- to employ AFM in the study of in situ glycation of collagen I (Paper II)
- to develop a method for the separation of human lipoprotein particles and study the effect
of selected sugars on the separation by CE in uncoated capillary (Paper III)
- to establish the influence of the sugars on the size of lipoprotein particles using AsFlFFF,
DLS, and MD simulations (Paper III)
- to develop a reliable covalent polycationic coating for rapid separation of biomolecules,
such us proteins, peptides, and lipoproteins (Paper IV)
- to investigate and determine the affinity constants of the interactions between human apoE
isoforms of HDL and C6S by PF-ACE–AED approach (Paper V).
18
2 Background to the work
2.1 Overview of miniaturized analytical techniques used for clarification of biomolecular
interactions
This section presents a description of the most sophisticated current techniques for the elucidation
of interactions involved in biological processes. Biomolecular interactions involved in biological
processes can be characterized with the help of CET, optical and acoustic biosensors, scanning
electron microscopy (SEM), and AFM [1,5-17]. The goal in employing these techniques is to
overcome and improve the technological limitations of other methodologies, still employed in
many laboratories. The strength of biomolecular interactions is generally evaluated as association
or dissociation constants, partition coefficients, retention factors, or reduced mobilities.
CET can be divided into two groups: CE and electrically driven capillary chromatographic
techniques. All of them have many advantages over traditional techniques: viz., high separation
selectivity, small sample-size, high-speed analysis, high separation efficiency, versatility,
robustness, excellent mass sensitivity, low reagent consumption, and high recovery when surface
adsorption is minimized. Relatively easy extrapolation to micro-fabricated microchannel
structures is a further advantage. CET have been widely explored in the separation of biomolecules
and evaluation of their interactions under various conditions [5,7-12]. One limitation of CE
separations is the strong and unfavorable adsorption of cationic analytes onto the inner wall of the
fused silica capillary, which results in losses in separation efficiency and resolution and in low
protein recoveries [18-21]. To avoid adsorption problems, the silanol groups on the inner wall of
the capillary are often masked by applying a dynamic or permanent coating, high ionic strength,
and/or background electrolyte (BGE) solutions with extreme pH values [22-25]. Polymers are
attached physically or covalently to the capillary wall, to increase the separation efficiency and the
repeatability of analysis [24-29]. Frequently, a basic requirement for the polymer has been the
simplicity of the coating procedure,  meaning that  the sole step is  rinsing of the capillary with a
fresh polymer solution. Unexpected interactions and instability of the coating may nevertheless
conspire to reduce the robustness of the technique.
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The  strong  adsorption  of  positively  charged  biomaterials  can  be  exploited  in  the  study  of
nanodomains of biological importance carried out by another CET—capillary
electrochromatography (CEC), especially open tubular CEC (OT-CEC) [5,7,9,30-41]. CEC
systems offer great potential for robust and reliable in situ studies of oxidation, enzymatic
interactions, and aggregation under a variety of conditions and in reasonable time span [8,9,31].
Typical parameters followed in these interaction studies are electroosmotic flow (EOF) mobility
and retention factors.
PF-ACE was developed from affinity capillary electrophoresis (ACE) and is characterized by
small sample and reagent consumptions, relatively fast analysis times, conduction in a free solution
(no need to bind ligand to a surface), and no requirement for sample purification before injection
so long as the component of interest can be separated from other species [42,43]. PF-ACE has
been employed for the investigation of bimolecular non-covalent interactions and for estimation
of the binding constants of complexes [10-12,24,42-46]. Furthermore, PF-ACE has shown great
potential for the clarification of dipole–dipole, hydrogen bonding, and protein–carbohydrate
interactions important in the pharmaceutical industry [43,47-51]. In addition, the PF-ACE
approach has recently been utilized to determine affinity constants of the interactions between
lipoprotein particles, steroids, and ECM components [10-12,24].
The interactions of biochemical processes can also be studied with the aid of biosensors. Optical
biosensor-based surface plasmon resonance (SPR) and acoustic biosensor-based QCM are the
most widely used techniques when binding processes need to be controlled in real time during a
steady-state analysis [13,52-54]. Recently, they have been utilized in the elucidation of very weak,
weak, moderate, and strong interactions such as are important in antibody and antigen analysis
[6,10-13,55]. QCM provides considerable advantages over SPR since the acoustic biosensor
response is sensitive to the charge of receptor–ligand complexes and, in addition to the changes in
viscoelastic properties, detailed information can be obtained about affinity constants and cell
adhesion processes. Further, QCM permits the direct injection of crude samples and has higher
mass sensitivity than SPR ( ௙௚
௠௠మ
 vs. ௣௚
௠௠మ
) [54,56].
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Electron and force-microscope methods, including SEM and AFM, have commonly been
employed to characterize and understand the interactions of biological nanodomains [1,14-16].
Both SEM and AFM provide topographical visualization of the surface allowing detailed studies
at atomic and molecular levels. A distinct advantage of AFM over SEM is the possibility to scan
in any medium, and in physiological conditions. By contrast, an electron microscope operates
properly only in an expensive vacuum environment. AFM allows the study of biological
macromolecules and even living organisms [1,2,16,17,57-59].
MD simulations and AED calculations are also essential for any detailed elucidation of binding
processes [60-65]. These methods act as excellent tools to answer questions that are difficult or
even impossible to approach experimentally at the molecular level. Both MD simulations and AED
calculations allow the determination of weak and strong interactions of binding processes, the
number of interactions per energy level, and the differences in energy of the interactions [60-65].
Mostly, they have provided complementary or supporting information for experimental studies.
Although instrumental analytical techniques give important information about chemical, physical,
and biological interactions, novel miniaturized techniques and new methods of research are still
needed to probe issues critical to the development of chronic diseases. Understanding of the
biological processes that occur in the ECM would help us to elucidate the factors promoting these
diseases and thus to develop more effective treatments and prevent premature death. The particular
focus of my study was to develop new methods applicable to understanding the initiation and
progression of atherosclerosis and diabetes.
2.2 Interactions between extracellular components and lipoprotein particles in the
development of atherosclerosis and diabetes
Over the years, much attention has been paid to the mechanisms behind the development of
atherosclerosis and diabetes [1-4]. Structural modifications of lipoprotein particles and collagens
are considered as a major risk factor implementing the development of several diseases. In the
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following sections, the composition of ECM, the structure of lipoproteins, and the relation of these
to atherosclerotic and diabetic plaque are shortly introduced.
2.2.1 Composition of the extracellular matrix
The ECM is a highly complex, tight network of macromolecules, which is present in all active
tissues and organs. Its task is to provide structural and biochemical support for the cells embedded
within tissues [66,67]. The ECM is made up of several different components, mainly fibrous
proteins and PGs.
Collagen is the most abundant fibrous protein in the human body tissue [68-70]. In all 29 collagens
that have been identified, the collagen molecule is composed of the repetitive sequence Glycine-
X-Y, where X is usually proline and Y hydroxyproline, and a triple helix structure where three a-
chains are twisted around each other [68,71]. Collagens I and III, the fibril-forming types, consist
of an uninterrupted right-handed triple helix approximately 300 nm in length and 1.5 nm in
diameter [72]. Fibrils are formed by self-assembly from a collagen molecule showing the D-
periodic banding pattern. Types I and III differ in structural composition: collagen I is composed
of two a1-chains and one a2-chain, which give it higher hydrophobicity than collagen III, whereas
collagen  III  consists  of  three  identical a1-chains. The collagen network is usually present in
association with decorin, a small leucine-rich PG, which is responsible for the organization and
fibrillogenesis of collagen in the ECM and, in addition, promotes the binding of LDL with
collagens [70].
Proteoglycans  are  a  structural  component  of  the  ECM  of  the  arterial  wall,  consisting  of
glycosaminoglycans (GAGs), which are unbranched carbohydrate polymers composed of
repeating disaccharide units. GAGs, mainly C6S, heparin, and dermatan sulfate (DS), interact
specifically with apolipoproteins of LDL and HDL such as apoB-100 and apoE, affecting their
functions [73].
22
2.2.2 Lipoprotein particles
Human plasma lipoprotein particles are lipid transport vehicles responsible for cholesterol and
triglyceride carriage in blood circulation [74]. Lipoproteins are generally classified according to
their density, size, and/or protein composition into five major groups: chylomicrons, very low
density lipoprotein (VLDL), intermediate density lipoprotein (IDL), LDL, and HDL. Spherical
lipoprotein particles consist of a hydrophobic core containing cholesterol esters, triglycerides, fatty
acids, and fat-soluble vitamins [75] and a surrounding hydrophilic layer composed of
apolipoproteins, a monolayer of phospholipids, and unesterified cholesterol. The different amounts
and compositions of lipids, apolipoproteins, and lipid transfer proteins give rise to the various
lipoprotein subclasses [76]. LDL and HDL particles are the most important cholesterol carriers.
LDLs provide the cell with cholesterol, while HDLs transfer accumulated cholesterol molecules
from the arterial intima to liver for extraction [76,77].
LDL contains just one major protein, apoB-100. Composed of 4536 amino acids, this is the largest
and most hydrophobic of the known monomeric proteins [78]. ApoB-100 is responsible for the
specific interactions of LDL particles with ECM structural components (collagen and PGs).
ApoE is an exchangeable apolipoprotein of VLDL and HDL particles, which participates in lipid
transport in human plasma and brain [73,79]. Human apoE appears in several different isoforms,
of which the best known, apoE2, apoE3 and apoE4, differ in the amino acids 112 and 158. These
amino acids affect the metabolic properties of the isoforms and their relation to diseases. ApoE2
(112-Cys; 158-Cys) binds defectively to LDL receptor and is linked to hyperlipoproteinemia type
III, while apoE3 (112-Cys; 158-Arg) interacts normally and is associated with balanced lipid
metabolism [73]. ApoE4 (112-Arg; 158-Arg), inherited from a parent, is present in about 25–30%
of the population and is considered as a major genetic factor in heart and neurodegenerative
disease, mainly Alzheimer disease.
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2.2.3 Atherosclerosis and diabetes
Atherosclerosis is a chronic inflammation of the arteries as well as a lipid metabolism disorder
[80]. The initiation of atherosclerosis is considered to involve an accumulation of the lipids derived
from human plasma LDL in the ECM of the inner layer of arterial  intima [81].  In this process,
LDL binds to ECM components through the positively charged residues of lysine and arginine of
apoB-100 to the negatively charged residues of PGs and collagen, promoting the entrapment of
the LDL particles in the intima in the process. Such binding is enhanced by the presence of decorin
[4,82]. Furthermore, the modifications of LDL particles by enzymes and/or oxidizing agents
trigger the fusion and aggregation of particles, affecting the strength of the binding between LDL
and arterial PGs and enhancing the deposition of LDL particles in the intima [81-84]. The
formation of atherosclerotic plaque narrows the arteries, limiting the blood circulation, and in the
worst case leading to stroke or premature death. Like apoB-100, apoE contains positively charged
amino acid regions, which mediate binding to GAGs. The retention of apoE-containing HDL
particles is a particular indicator of atherogenic processes.
Diabetes is a complex metabolic disorder, obstructing the production of insulin or the cell–insulin
response. It is characterized by a high level of glucose in the human blood circulation [85,86].
Slow non-enzymatic reaction between glucose and proteins or lipoproteins in the arterial wall is a
major mechanism for the development of atherosclerosis in diabetes [87]. Collagen, like other
long-lived proteins, can be glycated, giving rise to Schiff base formed through interaction of an
aldehyde group of the reducing glucose with an amino group of the protein, usually lysine residue.
The Schiff base subsequently rearranges into a more stable Amadori product and further to
irreversible advanced glycation end products (AGEs) [88]. As well, the modification of collagen
occurring during glycation not only leads to the formation of cross-linked structure, increased
stiffness, resistance against enzymatic hydrolysis, and variability in the affinity for plasma
lipoproteins but also to the functional disability of collagen and the resultant deposition of LDL
particles in the ECM [89-91].
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3 Techniques
Capillary electrophoresis, atomic force microscopy, and quartz crystal microbalance were selected
as the techniques of choice in the study. In addition, molecular dynamics simulations,
asymmetrical flow-field flow fractionation, and adsorption energy distribution calculations were
used to provide complementary or supporting information. A description of the employed
techniques is presented in the following sections.
3.1 Capillary electrophoresis
CE is a common analytical separation technique, where charged analytes, under the influence of
an electric field, migrate in solution in a narrow capillary on the basis of their charge, size, and
molecular structure. Simple and automated CE instrumentation requires only a capillary, two
background electrolyte containers, a high voltage power supply, and a detector (Figure 1). The
fused silica capillary, with inner diameter ranging from 25 to 100 mm and total length of 25–100
cm, connects the buffer containers, between which a potential up to 30 kV is applied. CE apparatus
usually is connected with a UV detector and controlled by a computer.
Figure 1. Schematic illustration of CE instrumentation.
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Fused silica capillary is characterized by the presence of silanol groups, which start to deprotonate
above pH 2–3. Overlying the negatively charged capillary wall surface is a double layer consisting
of a positively charged immobile layer, the so-called Stern or Helmholtz layer, and a diffuse layer
of cations. A potential difference is thereby created between the capillary wall and the bulk liquid.
Application of an electric field generates an EOF mobility, causing the diffuse layer, and with it
the bulk liquid within the capillary, to move toward the detector. The EOF dictates the direction
and magnitude of the solute ion flow within the BGE, and strongly depends on the BGE properties
as well as the surface charge of the fused silica capillary.
In CE, separation is effected solely on the basis of the differences in the electrophoretic mobilities
of the charged species. The total mobility of a charged analyte (mtot) can be described as a sum of
the electroosmotic mobility in the fused silica capillary (meo) and the electrophoretic mobility of
the analyte (mep).
ߤ௧௢௧ = 	 ߤ௘௢ + ߤ௘௣ (1)
Experimental determination of the migration time of the analyte (tm) allows calculation of the total
mobility of charged analyte according to the following equation:
ߤ௧௢௧ = ௅೏೐೟∙௅೟೚೟௏∙௧೘ (2)
where Ldet is the length of the capillary from injector to detector, Ltot is the total length of the
capillary, and V is the separation voltage.
PF-ACE is a versatile analytical technique for investigating bimolecular non-covalent interactions
and estimating binding constants of formed complexes [10-12,42,91]. The PF-ACE technique is
characterized by i) small number of analytes, ii) high reproducibility of data, iii) no requirement
for sample purification before injection as long as the studied component can be separated from
other species, and iv) no need for radiolabeling of the components [42].
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In PF-ACE, the capillary is partially filled with analyte and receptor, and the change in the
migration time of the formed complex relative to the migration times of analyte and receptor upon
voltage application is monitored. Briefly, short zones of analyte and then receptor are introduced
to the capillary and, upon voltage application; the zones start to move toward the detector (Figure
2). Differences in migration times allow the receptor zone to catch up to the analyte zone so that
complex formation can take place. PF-ACE can be performed either by adjusting the plug length
of the receptor zone introduced to the capillary or by applying the receptor over a wide
concentration range [43].
Figure 2. Schematic illustration of PF-ACE method.
Proper evaluation of the affinity constant (Ka) of a binding process requires that the conductivity
and field strength in the capillary be kept uniform [43]. The affinity constant can be determined
from the changes in migration times (Δݐ௠) as a function of the substance amount of receptor:
ܭ௔ = ଵ௄೏ = గ௥మ௅೏೐೟௧బ,೏೐೟ . ୢ୼௧೘ୢ୬ 	        (3)
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where ܭௗ is the dissociation constant, r is the inner radius of the capillary and ݐ଴,ௗ௘௧ is the time
needed for the analyte to reach the detector in the absence of receptor. The real volume of the
receptor zone in the capillary (VR) can be described as [43,49]
ோܸ = ܥோ ௙ܸ௜௟௟௜௡௚ ௔ܸ௣௣        (4)
where ܥோ and ௔ܸ௣௣  are concentration and apparent volume of the receptor zone in the capillary and
௙ܸ௜௟௟௜௡௚  is the injected volume of the receptor. ௙ܸ௜௟௟௜௡௚  can be expressed as [91]
௙ܸ௜௟௟௜௡௚ = ௧೑೔೗೗೔೙೒௧೟೚೟ೌ೗ ߨ	ݎଶܮௗ௘௧        (5)
where ݐ௙௜௟௟௜௡௚  is the filling time of the receptor and ݐ௧௢௧௔௟  is the time required for the receptor to
reach the detector under 50 mbar of pressure. The above equations can be modified to express the
affinity constant as
ܭ௔ = ௧೟೚೟ೌ೗௧బ,೏೐೟	஼ೃ 	௏ೌ ೛೛ . ୢ୼௧೘ୢ∆௧೑೔೗೗೔೙೒        (6)
where ∆ݐ௙௜௟௟௜௡௚  the changes in filling time of the receptor.
3.2 Atomic force microscopy
AFM belongs to the scanning probe microscopy family and measures the three-dimensional
topography of the surface with a sharpened cantilever tip. Physical properties are also measured
[92]. The cantilever probe is located close to the surface of interest and interacts with the associated
force fields. Then, the sharpened tip is scanned across the surface area and the surface profile is
reconstructed from the deflection of the backside of the cantilever reflected with a photodetector
(Figure 3).
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AFM has many advantages, of which the most important are visualization of the surface in
nanometer scale in 2D or 3D, precise motion control technology, high resolution, great sensitivity
at  nanometer  or  atomic  scale,  possibility  to  work  in  ambient  air  or  liquid  environment,  and
operability in numerous modes depending on the application. The contact and tapping modes are
most commonly applied for determination of the forces between a cantilever tip and the sample
area. The contact mode measures the deflection of the cantilever, which is in continuous contact
with the scanned surface, while the tapping mode measures the force interaction as the changes in
frequency and amplitude as the cantilever oscillates up and down over the surface.
Figure 3. Illustration of AFM operation.
3.3 Quartz crystal microbalance measurements
QCM is a novel microanalytical device that measures mass per unit area through determination of
the shift in frequency of a quartz crystal resonator [52]. Typically, the quartz crystals are a few
tens of millimeters in thickness and are cut in AT form at a 35o 25’ angle from the Z-axis. This
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provides a stable oscillation without temperature fluctuation at a certain frequency at room
temperature [54,93,94]. When an alternating electric field is applied through two metal (usually
gold) electrodes across a quartz crystal, mechanical oscillation is generated at a characteristic
frequency. Binding of mass to the crystal surface causes a decrease in frequency and the shift can
be recorded with an oscillator (Figure 4).
The equilibrium dissociation constants can be evaluated with a Scatchard plot or kinetic analysis
based on the following equation:
ܭௗ =	
ଵ
௄ೌ
= ௞೚೑೑
௞೚೙
       (7)
where ݇௢௙௙ and ݇௢௡ 	are dissociation and association rate constants, respectively, when A + B ó
AB.
Figure 4. Schematic illustration of QCM.
Recently, QCM has been successfully applied in the development of biosensors and in the binding
characterization from biopolymers, biochemical processes and cell-based assays, involving
screening and kinetic measurements, and on-line detection of bioaffinity interactions
[3,4,82,95,96]. Among the notable advantages of QCM for these purposes are the simple and
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automated instrumentation; the high sensitivity to the charge of receptor–ligand complexes and
the changes in viscoelastic properties; the possibility for direct injection of crude samples; and the
high mass sensitivity in the range of ௙௚
௠௠మ
 [54,56].
3.4 Adsorption energy distribution
AED calculations can be used in data interpretation to enable weak and strong interactions of the
binding processes to be distinguished. Adsorption isotherms describe the relation between
adsorbed and free concentrations of analyte at a constant and specific temperature [64,65,97]. The
simplest adsorption model describing homogeneous interactions (one adsorption energy) is the
Langmuir model, which can be expressed as
߆௕ = ௄ೌ஼ଵା௄ೌ஼ (8)
where ߆௕	is the bound molar fraction of analyte, ܭ௔ is the association equilibrium constant, and ܥ
concentration of analyte. Interactions are usually heterogeneous, however, and a simple model that
describes the interaction of two independent adsorption sites is the bi-Langmuir model:
߆௕ = ߆௠௔௫,ଵ ௄ೌ,భ஼ଵା௄ೌ,భ஼ + ߆௠௔௫,ଶ ௄ೌ,మ஼ଵା௄ೌ,మ஼ (9)
where ߆௠௔௫,௜  and ܭ௔,௜  are the monolayer saturation capacity and the association equilibrium
constant for the i:th adsorption site, respectively. In this model the sum of ߆௠௔௫,ଵ and ߆௠௔௫,ଶ is
equal to 1 and this constraint is used in the non-linear model fitting of the bi-Langmuir model. The
degree of heterogeneity in the energy of interactions is evaluated by AED calculations by
expanding Eq. (9) to a continuous distribution of independent adsorption sites over a defined
adsorption energy range. In this way, the adsorption isotherm becomes an integral equation, which
can be written as
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߆௕ = ∫ ݂(݈݊ܭ)߆(ܥ,ܭ)݈݀݊ܭ௄೘ೌೣ௄೘೔೙      (10)
where ߆(ܥ,ܭ) is the local adsorption isotherm model and ݂(݈݊ܭ) is the AED. Kmin and Kmax are
calculated from 0.1/ܥ௠௔௫  and 10/ܥ௠௜௡, respectively, where ܥ௠௔௫ is the maximum concentration
used in determination of the adsorption isotherm and ܥ௠௜௡ 	is the lowest concentration. The AED
is solved iteratively by the expectation maximization method [97].
To apply AED calculations in the PF-ACE data processing step and to determine the affinity
constant of the binding processes, first the adsorbed fraction of analyte should be established as a
function of the concentration of the receptor. The average mobility of the analyte–receptor
complex (μ஺) can be defined as [98]
μ஺ = 	 ߆௙μ௙ + ߆௕μ௕      (11)
where, ߆௙	is the free molar fraction of the analyte, μ௙ 	and μ௕ 	are the mobilities of the free and
bound molar fraction of the analyte. Because	߆௙ + ߆௕ = 1, the equation for the adsorbed fraction
can be written as
߆௕ = ஜಲିஜ೑ஜ್ିஜ೑      (12)
The mobilities of the adsorbed and free fractions were investigated with exponential and linear
fitting, respectively. At the lower end of the concentration range, electrophoretic mobility
decreases linearly toward the minimum value, where the analyte is entirely in free form. At the
high concentration end, where the analyte is totally bound to the receptor, electrophoretic mobility
reaches the maximum value.
3.5 Molecular dynamics simulations
MD simulations are a tool for theoretical study of a biomolecular system. The simulations provide
either detailed information about conformational changes or insight into the motion of interacting
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atoms and molecules during a specific period of time [99,100]. To enable MD simulations in
interaction studies, first the force field should be derived from the functional form and from the
set of parameters that characterize the potential energy of a system of molecules and atoms. The
typical parameter set includes values of atomic mass, van der Waals radius, and partial charge for
individual atoms; and equilibrium values of bond lengths, bond angles, and dihedral angles for
bonded atoms; and values corresponding to the effective spring constants for each potential. A
force field is established by empirical fitting from experimental data.
3.6 Asymmetrical flow field-flow fractionation
AsFlFFF is the most widely used field-flow fractionation technique today. It is suitable for the
separation and characterization of biological components, polymers, and particles over enormous
ranges of mass and size, at the same time providing direct measurements of particle size and
diffusion coefficients [101-104]. Separation of particles or macromolecules is controlled by the
differences in diffusion coefficients.
The movement of the cross-flow across the separation channel causes a larger particle with lower
diffusion coefficient to drift closer to the channel wall [101,102]. As a result, in normal mode, the
larger molecules elute slower than the smaller ones. Separation in AsFlFFF occurs in order of
increasing diameter or molar mass of the particles [101]. If there is no strong interaction between
particles and the accumulation wall, AsFlFFF gives accurate information about particle size.
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4 Experimental
This chapter lists the chemicals (Table 1), buffer solutions (Table 2), and equipment and devices
(Table 3) that were used, and briefly describes methods employed in the studies. Detailed
information can be found in Papers I-V.
4.1 Materials
Table 1. List of chemicals used in the studies.
Chemical Manufacturer Paper
10-Udecen-1-ol Sigma-Aldrich IV
1,3-Divinyltetramethyldisiloxane Sigma-Aldrich IV
2-Bromoisobutyryl bromide Sigma-Aldrich IV
2-(Methacryloyl)oxyethyl]trimethylammonium
chloride (MOTAC) Sigma-Aldrich IV
2,2-Bipyridyl Sigma-Aldrich IV
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES) Sigma-Aldrich I
4-Methylmorpholine (NMM) Sigma-Aldrich IV
9-Fluorenylmethoxycarbonyl (Fmoc) Sigma-Aldrich I
Acetic acid Sigma Chemical Co. I, IV
Alprenolol Sigma-Aldrich IV
Atenolol Sigma-Aldrich IV
Apolipoprotein B-100 peptide residue Meilahti Protein Chemistry Facility I
Apolipoprotein E peptide residue Meilahti Protein Chemistry Facility V
Azobisisobutyronitrile Fluka IV
Bovine pancreas α-chymotrypsinogen Sigma-Aldrich IV
Bovine serum albumin (BSA) Sigma-Aldrich III, IV, V
Chicken egg white lysozyme Sigma-Aldrich IV
Chondroitin-6-sulfate Sigma-Aldrich V
Collagen type I Sigma-Aldrich I, II
Collagen type III Sigma-Aldrich I
Copper (I) bromide Sigma-Aldrich IV
Cyanomethyl methyl(phenyl) carbamodithiate Sigma-Aldrich IV
D-Glucose 6-phosphate sodium salt Fluka II
Decorin Sigma-Aldrich I
Dextran Sigma-Aldrich III
Dichloromethane Mallinckrodt IV
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Chemical Manufacturer Paper
Dimethyl sulfoxide LabScan III, IV, V
Ethylenediaminetetraacetic acid (EDTA) Sigma Chemical Co. III, IV, V
Fructose Merck III
Glucose Merck III
H2[PtCl6] H2O Sigma-Aldrich IV
Horse heart cytochrome C Sigma-Aldrich IV
Hydrochloric acid Merck I-V
Labetalol Sigma-Aldrich IV
Maltose monohydrate Merck III
Methanol Sigma-Aldrich IV
Metoprolol Sigma-Aldrich IV
n-Hexane Rathburn Chemicals IV
NH4HCO3 Sigma-Aldrich V
N,N-Diisopropylethylamine (DIEA) Sigma-Aldrich I
N,N-Dimethylformamide (DMF) Rathburn Chemicals I
O-(6-Chlorobenzotriazol-1-yl)-N,N,N´,N´-
tetramethyluronium hexafluorophosphate (HCTU) Sigma-Aldrich I
Pindolol Sigma-Aldrich IV
pET32a vector Novagen V
Poly(2-vinylpyridine)-block-(ethylene oxide)
(P2VP-b-PEO) Polymer Source Inc. V
Potassium bromide Sigma-Aldrich III, IV, V
Pyridine Merck IV
Sorbitol Merck III
Sodium bicarbonate Merck IV
Sodium hydroxide Oy FF-Chemicals Ab I-V
Sodium sulfate Kebo-Lab IV
Sucrose Sigma-Aldrich III
Tetrahydrofuran (THF) Rathburn Chemicals IV
Toluene Riedel-de Haen IV
Trichlorosilane Sigma-Aldrich IV
Trifluoroacteic acid (TFA) Sigma-Aldrich I
Trifluoroethanol Sigma-Aldrich IV
Triisoprolylsilane (TIS) Sigma-Aldrich I
The pH was adjusted to desired value with 1.0 M hydrochloric acid or 1.0 M sodium hydroxide.
Before use, the BGEs were filtered through 0.45-mm Millipore filters using a Millipore vacuum
system. The details of the buffer preparations can be found in the relevant papers.
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Table 2. Buffer solutions employed in the experiments.
BGE pH Ionic strength Paper
Acetate 4.0-5.0 10-40 mM IV
HEPES 7.4 20 mM I
HEPES + NaCl 7.4 20 mM, 135 mM NaCl I
Phosphate 3.0, 5.0-8.0 5-40 mM I-V
Phosphate + NaCl 7.4 20 mM, 135 mM NaCl I
Table 3. Equipment and devices used in the work.
Equipment or device Model and Manufacturer Paper
Atomic force microscope Veeco Instruments Multimode V;Nanoscope V controller I, II
Asymmetrical flow field-flow
fractionation equipment Constructed in-house III
C18 reversed-phase column Supelco Discovery wide-pore I
Cholesterol kit Roche Diagnostics III
Escherichia coli BL21 New England Biolabs Inc. V
FT-IR spectrometer Nicolet 388, Thermo Scientific IV
His-Bind Resin Chromatography Kit Novagen V
HiTrap Heparin-Sepharose column Amersham Biosciences V
MALDI-TOF/TOF MS AutoFlex III, Bruker I
Membrane for dialysis Spectrator I, II
Millipore filters Bedford I-V
Millipore water purification system Millipore SA I-V
MultiPep synthesizer Intavis Ag I
Muscovite mica YA-Kemia, Sigma-Aldrich I
NMR spectrometer AVANE DPX499, Bruker V
pH meter Jenway 3030 I-V
pH meter MeterLab PHM220, Radiometer I-V
Polycarbonate open-top centrifuge
tube Beckman III, IV, V
Rectangular phosphorus-doped Si
cantilevers Veeco I, II
Silicon dioxide sensor chip Attana AB I
Ultracentrifuge 100.2, 80 and 50.2 Ti rotors;Beckman Optima TL Table-Top III, IV, V
Ultrahydrogel precolumn UltrahydrogelTM IV
Uncoated fused silica capillary Optronis GmbH I-V
Water bath MGW Lauda K2, Lauda-Königshofen I-V
Zetasizer Nano ZS Nano ZS Malvern Instruments III, IV
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4.2 Methods
4.2.1 Preparation of lipoprotein particles
Isolation of human lipoproteins by ultracentrifugation in the presence of sugars
Human lipoproteins were isolated from the plasma of healthy volunteers by ultracentrifugation in
the presence of sugar solution applied to form a density gradient [105]. Briefly, 800 mL volume of
plasma was layered onto 1600 mL of 20% (m/m) sugar solution in a 3.0 mL polycarbonate open-
top centrifuge tube. The tube was spun for 4 h 10 min at 100 000 rpm at 20 oC in a Beckman
Optima TLA-100.2 ultracentrifuge rotor (435 000 gmax). Then, the supernatant was divided into
8 fractions and the cholesterol level was determined in each fraction [106] (Paper III).
Isolation of human lipoproteins by ultracentrifugation in the presence of KBr
Human LDL (d = 1.019-1.050 g/mL) was isolated from the plasma of healthy volunteers by
sequential ultracentrifugation in the presence of 3 mM EDTA [107,108]. Briefly, solid KBr was
added to plasma to adjust its density to 1.019 g/mL. Then, the floated VLDL and IDL particles
were collected, and the density of the bottom fractions was adjusted to 1.050 g/mL with solid KBr.
The centrifuge tube was spun in a Beckman Ti 50.2 rotor (148 000 gmax) for 72 h at 35 000 rpm,
and LDL was obtained from the top of the tube. Next, the fractions were centrifuged (d = 1.060
g/mL) at 35 000 rpm in a Beckman Ti 80 rotor (115 000 gmax) for 24 h and dialyzed extensively
against LDL buffer solution (1 mM EDTA and 150 mM sodium chloride in water; pH 7.4). The
amount of LDL, expressed in terms of its protein concentration, was determined by the method of
Lowry et al. [109] with BSA as a standard. The dialyzed LDL samples were stored at 4 oC. (Papers
III, IV)
Human HDL2 (d = 1.063-1.125 g/mL) and HDL3 (d = 1.125-1.21 g/mL) were isolated by
sequential ultracentrifugation of using solid KBr to adjust the densities in each step [107]. The
HDL subclasses were washed by reflotation at their upper density (1.125 g/mL for HDL2 and 1.21
g/mL for HDL3). All centrifugation steps were performed in a Beckman Ti 50.2 rotor (300 000
gmax) at 50 000 rpm for 40 h at 5 oC. Then HDL and its subclasses were dialyzed against 20 mM
phosphate buffer at pH 7.4 in the presence of 140 mM NaCl to remove KBr. The dialyzed HDL
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subclasses were stored at 4 oC. Protein and lipid contents (% m/m) were determined by standard
methods [110] (Papers III, IV, V).
Purification of apoE-containing HDL particles was performed by Heparin-Sepharose affinity
chromatography [111]. Briefly, HiTrap Heparin-Sepharose column was equilibrated with 5 mM
Tris-HCl and 50 mM NaCl at pH 7.4 with a flow rate of 0.5 mL/min. HDL solution to which solid
MnCl2 had been added to give a final concentration of 25 mM of Mn2+ was loaded onto the column,
and the column was then washed with 5 mM Tris-HCl, 50 mM NaCl, and 25 mM MnCl2 at pH 7.4
until the A280 reached the baseline. The bound apoE-containing HDL particles were eluted with
5 mM Tris-HCl, 100 mM NaCl at pH 7.4. Fractions of 1 ml were collected, pooled, dialyzed
against PBS buffer, and stored at + 4 oC (Paper V)
4.2.2 Production and purification of apolipoproteins
Apolipoprotein B-100
The apoB-100 peptide residue (3359–3377) with 19 amino acids and net charge of +6 was
produced by standard solid-phase synthesis via Fmoc chemistry on Wang resin preloaded with C-
terminal  amino  acid.  Synthesis  was  performed in  25  mmol  scale  on  a  MultiPep  synthesizer  by
double coupling and activation with 1:1:2 amino acid/HCTU/NMM. Amino acids with standard
side-chain protecting groups were used in four-fold excess to resin to ensure maximal coupling
under the preactivation with 0.5 M HCTU/4 M NMM in DMF. After the coupling and subsequent
DMF wash cycles the unreacted peptide chain was capped by acetylation in 50 mM acetic
anhydride/130 mM DIEA in DMF. Fmoc deprotection after each amino acid cycle was done twice
with 25% piperidine in DMF. The synthesis product was dried on resin and cleaved in 5 ml of
cleavage mix: 95% TFA / 2.5% TIS / 2.5% H2O to remove the side-chain protecting groups and
detach the peptide. After 2 h incubation at room temperature, the resin eluate was filtered, and the
solution containing the newly synthesized peptide was evaporated under nitrogen flow (99.99%)
to approximately 20% of the volume. Peptide was precipitated with 10-fold volume of tert-butyl
methyl ether, centrifuged in an explosion-proof centrifuge, washed once with ether, solubilized in
water, and lyophilized. Peptide powder was resolubilized in DMSO and purified in a C18 reversed-
phase column with 10 column volumes of 0–70% acetonitrile/H2O gradient. The purified peptide
38
of interest was quality controlled by MALDI-TOF/TOF mass spectrometry. About 5 pmol of the
solubilized peptide was mixed with saturated a-cyano-4-hydroxycinnamic acid matrix solution (1
part of 0.1% trifluoro acetic acid in water to 2 parts of MS-grade acetonitrile). If necessary, peptide
was further de-novo sequenced by TOF/TOF (Paper I).
Apolipoprotein E
Constructs of apoE were obtained from Dr. Karl H. Weisgraber (Gladstone Institute of
Cardiovascular Disease, San Francisco, CA). The human cDNAs of apoE2, apoE3, and apoE4
were transformed into a pET32a vector, which codes an N-terminal His6 tag and a fusion
expression partner, thioredoxin [112]. The apoE-containing vectors were modified with a T7
expression  strain  BL21  of Escherichia coli and  purified  with  use  of  a  His-Bind  Resin
Chromatography Kit. Thrombin digestion was done at room temperature for 30 min at a ratio of
1:500 (thrombin:apoE, m/m). Delipidation of apoE was performed as described previously [113].
Heparin-Sepharose affinity chromatography was employed in the last step of apoE purification.
Briefly, the delipidated apoE was diluted in PBS containing 5 M urea and 0.1% of 2-
mercaptoethanol at pH 7.4. Then, the apoE sample was loaded onto 5 ml Heparin-Sepharose
column that was equilibrated with the 5 M urea buffer at a flow rate of 1 ml/min. Elution of bound
apoE was performed with 1 M NaCl in 5 M urea buffer. Finally, the eluted apoE was dialyzed
against 100 mM NH4HCO3 at pH 8.0. Purified apoE isoforms displayed one-band staining in SDS–
PAGE analysis with an apparent molecular mass of 34 kDa (Paper V).
4.2.3 Preparation of coating solutions
Collagen I coating
Stock solution of collagen I (1 mg/mL in acetic acid 0.1 M) was dialyzed against phosphate buffer
solution pH 7.4, I 20 mM for 3 h at 4 oC. Then, collagen I was diluted in phosphate buffer pH 7.4,
I 20 mM to get 0.5 mg/mL as final collagen I concentration. The collagen solution was immediately
employed in the coating procedure (Papers I, II).
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Collagen I–decorin coating
Stock solution of collagen I (1 mg/mL in acetic acid 0.1 M) was dialyzed against phosphate buffer
pH 7.4, I 20 mM containing 135 mM NaCl for 3 h at 4 oC. After dialysis, collagen I was mixed
with decorin and diluted in 20 mM phosphate buffer at pH 7.4 in the presence of 135 mM NaCl to
obtain 0.5 mg/mL as final collagen I concentration and 0.025 mg/mL as final decorin
concentration. The solution was applied immediately for the coating of the substrate (Paper I).
Collagen III coating
Stock  solution  of  collagen  III  (1  mg/mL  in  acetic  acid  0.1  M)  was  dialyzed  overnight  against
HEPES buffer pH 7.4, I 20 mM containing 135 mM NaCl at 4 oC. Collagen III was diluted in
HEPES buffer pH 7.4, I 20 mM in the presence of 135 mM NaCl to obtain 0.3 mg/mL as final
collagen III concentration, and then immediately submitted to the coating procedure (Paper I).
Collagen III–decorin coating
Stock  solution  of  collagen  III  (1  mg/mL  in  acetic  acid  0.1  M)  was  dialyzed  overnight  against
HEPES buffer pH 7.4, I 20 mM containing 135 mM NaCl at 4 oC. After dialysis, collagen III was
mixed with decorin and diluted in 20 mM HEPES buffer at  pH 7.4 in the presence of 135 mM
NaCl to obtain 0.3 mg/mL as final collagen III concentration and 0.015 mg/mL as final decorin
concentration. The solution was immediately applied to the coating procedure (Paper I).
Glycation of collagen I
The stock solution of D-glucose 6-phosphate (10.2 mg/mL) was prepared in MilliQ water with the
addition of NaN3 (final concentration 3 mM) to prevent bacterial growth and stored at 4 oC. Before
use, the sugar solution was diluted with 20 mM phosphate buffer at pH 7.4 to obtain 5.2 mg/mL
as final glucose concentration (Paper II).
PMOTAC coating
Atom transfer radical polymerization (ATRP) technique was applied to polymerize MOTAC on
the fused silica capillary. A typical reaction solution was prepared as follows: 0.22 mmol of 2,2-
bipyridyl was mixed with 2.04 mmol of 80% m/m MOTAC solution and the mixture was dissolved
in 25 mL of water/propan-2-ol 50:50 mixture. The reaction mixture was purged with N2 gas for 40
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min to remove oxygen. The poly[2-(methacryloyl)oxyethyl]trimethylammonium chloride
(PMOTAC) reference polymer was prepared by reversible addition-fragmentation chain transfer
polymerization technique. Briefly, 14.6 mmol of MOTAC, 0.006 mmol of azobisisobutyronitrile,
and 0.05 mmol of cyanomethylmethyl(phenyl) carbamodithioate were mixed in 20 mL of
trifluoroethanol. The reaction vessel was degassed with five freeze–thaw pump cycles. Next, the
mixture was placed in a preheated oil bath for 4 h at 60 oC. After that, the product was dialyzed
against water. The molecular weight of the polymer is 220 000 g/mol and the polydispersity index
is 1.82 (Paper IV).
P2QVP-b-PEO coating
Unmodified poly(2-vinylpyridine)-block-poly(ethylene oxide) (P2VP-b-PEO) block copolymer
(10.5 mg) was dissolved completely in 3 mL of DMF. Then, an excess (60 equivalents) of MeI
was added dropwise to the block copolymer solution, and the solution was stirred at ambient
temperature for 3 days in darkness. During that time the solution changed from colorless to slightly
yellow. Next, the excess of the MeI and a small amount of the DMF were evaporated with a rotary
evaporator. The solvent medium was then replaced during dialysis against water for 3 days.
Finally, the solution was lyophilized for 2 days. Characterization of the quaternized block
copolymers was carried out by FT-IR spectroscopy and 1H-NMR spectroscopy (Paper V).
4.2.4 Immobilization of coatings
Before use, all substrates were pretreated to remove impurities from the surfaces and thus to
improve the immobilization procedure. The pretreatments that were applied are described in Table
4.
After the pretreatment procedure, substrates were exposed to the coating solutions to achieve
uniform and repeatable platforms for the interaction studies (Papers I, II). In case of the fused silica
capillary, the capillary was coated with either PMOTAC or P2QVP-b-PEO polymer to diminish
strong and unfavorable analyte adsorption on the capillary wall and create a positive or neutral
surface (Papers IV, V).
41
Table 4. Pretreatment of substrate.
Substrate Pretreatment Temperature Notes
Fused silica capillary
Muscovite mica
SiO2 sensor chip
1 M HCl 15 min
MilliQ water 15 min
1 M HCl 15 min
MilliQ water 15 min
37 oC, water bath
Ex situ in a vial;
before the AFM
and QCM
measurements
(Paper I)
Fused silica capillary
1 M HCl 20 min
0.1 M HCl 10 min
MilliQ water 25 min
BGE solution 5 min
25 oC,
CE temperature control
In situ;
before the
separation
studies and
P2QVP-b-PEO
coating
(Papers II, III)
Fused silica capillary
1 M HCl 15 min
0.1 M HCl 10 min
1 M NaOH 15 min
MilliQ water 15 min
BGE solution 5 min
25 oC,
CE temperature control
In situ;
before the
MOTAC
coating
(Paper III)
In the studies with collagen I and III and their decorin-modified films, fused silica capillary,
muscovite mica, and SiO2 sensor chip were exposed to the coating solution for 160 min and treated
for 30 min with BGE solution at pH 7.4 In the case of glycation studies, the fused silica capillary
was coated with collagen I, treated with D-glucose 6-phosphate solution for 40 min, and left to
stand in the glucose solution for the selected intervals (8, 16, and 24 h). Glycation was stopped by
immersing the coated capillary in phosphate buffer at pH 7.4, I 20 mM for 10 min. Coated fused
silica  and  mica  substrates  were  stored  at  pH  7.4  until  submission  to  AFM  measurement.  The
collagen-coated silicon dioxide sensor chips were stabilized overnight at 25 oC under continuous
flow (10 ml/min) of BGE in the Attana A100 QCM biosensor. Equilibration was established when
the baseline drift yielded <5 Hz/min (Papers I, II).
For the PMOTAC coating, after the pretreatment the capillary was purged with N2 gas for 1 h at
room temperature, then rinsed with the silanization reagent for 20 min and with trimethylamine–
methanol  solution  (v/v,  1:1)  for  5  min  at  50  mbar.  Triethylamine  was  used  to  neutralize  the
hydrochloric acid that formed during the silanization process. The silanization–triethylamine
sequence was repeated five times. Next, both ends of the capillary were sealed and the capillary
was left to stand for 24 h. Unreacted silanization reagent was removed by treating the capillary for
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20 min with toluene, 20 min with methanol, and 20 min with dichloromethane at pressure of 940
mbar. Before the polymerization, the capillary was purged with N2 gas for 1.5 h. Then the capillary
was flushed for 80 min with MOTAC monomer solution. Both ends of the capillary were sealed
and the capillary was left to polymerize for 24 h, after which it was flushed for 1 h with Milli-Q
water and for 30 min with a BGE solution (phosphate buffer, pH 7.4, I 20 mM) at a pressure of
940 mbar (Paper IV).
In the case of the P2QVP-b-PEO coating, the capillary wall was coated with quaternized double-
hydrophilic diblock copolymer [114]. Briefly, after the pretreatment, the capillary was rinsed with
the copolymer solution for 40 min and then left to stand for 30 min. Excess of the P2QVP-b-PEO
solution was removed by washing the capillary for 60 min with BGE solution (phosphate buffer,
pH 7.4, I 20mM) at a pressure of 940 mbar (Paper V).
4.2.5 Evaluation of the coatings
To ensure the interaction and separation studies of biomolecules, all capillary coatings were
verified by EOF measurements, and the PMOTAC coating was additionally verified in the
separation of model compounds.
In the EOF measurements, DMSO was used as EOF marker (0.05%, v/v) to evaluate the stability
of the coating in the different coating steps. Before each EOF measurement, the capillary was
flushed with BGE solution for 2 min to equilibrate the surface. Most of the run conditions were as
follows: pressure 50 mbar, voltage ± 20 kV, injection 2–5 s, temperature 25 oC, Ldet 30 cm, Ltot
38.5 cm. Detection was performed at 200–214 nm (Papers III, IV). The method of Williams and
Vigh was exploited for evaluation of the neutral P2QVP-b-PEO coating (Paper V) [115].
The usefulness of the positive PMOTAC coating in the separation studies was evaluated with three
sets of model compounds: three basic proteins, five β-blockers, and lipoproteins. Runs were
performed under  the  following  conditions:  voltage  from -5  to  -20  kV,  injection  2  s  at  50  mbar
pressure, temperature 25 oC, Ldet 30 cm, Ltot 38.5 cm, and detection at 200–214 nm. Between runs,
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the capillary was preconditioned with BGE for 2 min. All separations were carried out in pH range
3–5 (I 20 mM) (Paper IV).
4.2.6 Instrumental methods and calculations
Partial filling affinity capillary electrophoresis
PF-ACE measurements were carried out to evaluate the interactions of C6S with apoE isoforms
and apoE-containing HDL2. The procedure has been described in recent papers from the laboratory
[10-12,91].  Briefly,  the capillary was partially filled with either isoform of apoE or with apoE-
containing HDL2 for 2 s, after which C6S was added for 3 s in concentrations ranging from 0.0
mg/mL to 1.0 mg/mL. Next, a voltage of -25 kV was applied, and both analytes started to move
toward the anode at the detector end. Highly negatively charged C6S overtook the negatively
charged isoform of apoE or apoE-containing HDL2 and the resulting complex moved to the
detector. Detection was at 200 nm. Before each run, the capillary was equilibrated by rinsing for
2 min with the BGE solution (phosphate buffer, pH 7.4, I 20mM). All measurements were carried
out at 25 oC (Paper V).
Adsorption energy distribution calculations
The multiple binding sites for the interactions were evaluated with AED calculations. Affinity
constants were determined in three steps: 1) Scatchard plot analysis to gain preliminary insight
into the adsorption characteristics, 2) AED calculations to gain insight into the heterogeneity of
the adsorption isotherm models before the actual model fitting, and 3) fitting of feasible adsorption
models (according to the previous two steps) to the raw data and comparison of the model fits with
classical F-tests [116]. This three-step procedure allowed distinguishing of the strong and weak
interactions and clarification of the heterogeneity of the binding processes (Paper V).
Atomic force microscopy measurements
The AFM measurements were performed to evaluate the shape, size, and structure of the collagen
coatings. Intermittent-contact (tapping) mode in air was applied at ambient temperature and
humidity  (T  =  21 ± 1 oC; RH = 25%) using Veeco RTESP rectangular phosphorous-doped Si
cantilevers. Measurements were carried out on random fragments of coated substrate with a
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scanning frequency of 0.5 Hz to demonstrate the presence of the coating and to select
representative samples for further studies. All images were captured from a scanning area of 1 mm
x 1 mm (Papers I, II).
Quartz crystal microbalance measurements
A QCM biosensor was used to determine equilibrium dissociation constants on different collagen
coatings. All studies were carried out under continuous flow (25 mL/min) of running buffer at 25
oC. Characteristics of interactions between immobilized collagen films and apoB-100 were
clarified by injecting increasing concentrations of apoB-100 peptide fragment for 84 s over the
various collagen films, and dissociation was recorded for 216 s before surface regeneration. All
experiments were performed in duplicate. The equilibrium dissociation constant was then
determined by Scatchard plot analysis of the QCM data (Paper I).
Molecular dynamics simulations
MD simulations were conducted to study the effects of sugars on the apolipoprotein structure of
human lipoproteins. Peptide fragments apoB-100 (3359–3377) and apoE (136–150), the crucial
apolipoproteins of HDL and LDL particles, respectively, were chosen for the studies. The sugars
were cyclic isomers of glucose, maltose, and sucrose. The effect of these sugars was investigated
at different levels. A detailed description of the MD simulations can be found in Paper III.
Asymmetrical flow field-flow fractionation measurements
AsFlFFF was used to measure the size distribution of lipoprotein particles HDL and LDL after and
before sugar treatments. The AsFlFFF carrier liquid was 9 mM phosphate buffer pH 7.4, I 20mM
containing 140 mM NaCl. The actual channel thickness was calculated at 21 oC from 1 mg/mL
BSA solution in 9 mM phosphate buffer pH 7.4, I 20 mM containing 140 mM NaCl. In this
solution, the diffusion coefficient of BSA is equal to 6.29×10 -11 m2/s. The repeatability of the
results was determined with four runs of HDL and two runs of LDL samples (Paper III).
Dynamic light scattering measurements
The size distribution of lipoproteins and the hydrodynamic dimensions of the free PMOTAC were
determined by DLS measurements (Papers III and IV, respectively). One run consisted of 12
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individual measurements, and the results were presented as the mean values of five runs. All
measurements were made at 25 oC. In the lipoprotein studies, experiments were done in phosphate
buffer at pH 7.4, I 20 mM, while in the PMOTAC studies they were done in acetate and phosphate
buffer in pH range 3–8, I 20 mM.
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5 Results and discussion
The starting point of the research described in this thesis was the discovery in our laboratory that
OT-CEC is an excellent platform for the investigation of collagen surfaces under various
experimental conditions [5,7]. Detailed information about the structure, size, and shape of the
collagens was first obtained by AFM (Papers I, II). The collagens, immobilized on fused silica and
mica substrates, were explored in terms of their ability to bind decorin and of the effect of glucose
exposure. QCM measurements were exploited (Paper I) to obtain information on the interactions
of the same collagen surfaces with apoB-100, the main apolipoprotein of LDL.
The strong adsorption of lipoprotein particles on the fused silica capillary wall makes their
separation a highly demanding task [117]. In previous studies in our laboratory, lipoprotein
adsorption on fused silica capillary was tested and exploited as a microreactor for interaction
studies [30-33]. In my work, in contrast, monosaccharides, disaccharides, and one sugar alcohol
were applied to increase the density of plasma and prevent undesired adsorption onto the fused
silica capillary before preparative ultracentrifugation (Paper III). Sucrose was known to bind
irreversibly to lipoprotein particles [118], and it could be assumed to minimize the electrostatic
interactions of positively charged amino acids of the lipoproteins with the negatively charged fused
silica surface. Sugars were tested as a coating material for the capillary and as additives in the BGE
solution, to diminish the adsorption and allow selective separation of lipoproteins in uncoated
capillary. Further, AsFlFFF, DLS, and MD simulations were exploited to elucidate the effect of
sugars  on  the  size  of  lipoprotein  particles  and  to  clarify  their  influence  on  the  structures  of
apolipoproteins.
Another feasible approach to eliminating the adsorption of lipoproteins on the inner wall of the
fused  silica  capillary  is  to  mask  the  silanol  groups  with  either  dynamic  or  permanent  polymer
coating. The denaturation of analytes and their unwanted interactions with BGE surfactants are
thereby avoided. Although dozens of coatings are available, novel platforms able to provide highly
efficient separation and repeatable analysis are always of interest. The particular goal of my
research in this respect was to develop a covalent polycationic coating that would provide
successful separations of model compounds as well as promising separations of lipoprotein
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particles (Paper IV). Although, the coating proved suitable for the separation of small proteins and
for clinical screening, the separation of lipoproteins was not satisfactory. Just recently, a neutral
platform with hydrophilic properties for the separation and interaction studies of biomolecules
under physiological conditions was developed in the laboratory [12,114], and this platform was
successfully exploited in PF-ACE to clarify the weak and strong interactions between
apolipoproteins and lipoproteins and extracellular components (Paper V). At the same time,
adsorption energy distribution calculations were exploited to determine the affinity constants of
the interactions.
This chapter presents and summarizes the major findings of the research.
5.1 Studies on collagen types I and III
5.1.1 Fibrillogenesis of collagen and collagen–decorin coatings
The great complexity of collagens and the modifications they undergo under different conditions
made the fibrillogenesis studies a demanding task. Collagen types I and III were immobilized on
fused silica capillary and mica substrates by the relatively simple procedure developed earlier in
our laboratory [7]. The results showed that dialysis was essential to obtaining a homogeneous
collagen solution for immobilization that also would ensure stable and repeatable coatings. In
addition, the selection of the buffer was crucial for the stability of the coatings. The phosphate
buffer solution pH 7.4, I 20 mM was chosen for collagen I and the HEPES buffer solution pH 7.4
with 135 mM NaCl for the more hydrophilic collagen III film. As can be seen from Figure 5,
collagen I adsorbed more easily on the hydrophobic fused silica surface, forming long, thick, and
randomly distributed fibrils (Figure 5a), while on the mica it formed short and thin fibrils in a
tightly packed netlike structure (Figure 5e). Collagen III, in turn, adsorbed more strongly on the
mica substrate than on fused silica: on mica the fibrils were longer, thicker, and more uniformly
located, whereas on fused silica they appeared as a fibrous branched network (Figure 5c and 5g).
A possible explanation of the differences in the adsorption patterns is the difference in structure of
collagens  I  and  III.  Type  III  is  more  hydrophilic  than  type  I  due  to  the  larger  amount  of
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hydroxyproline groups [68], and this results in stronger adsorption on hydrophilic substrates such
us mica.
Figure 5. AFM images of a) collagen I, b) collagen I–decorin, c) collagen III, and d) collagen III–
decorin coatings adsorbed on fused silica surface, and e) collagen I, f) collagen I–decorin, g)
collagen III, and h) collagen III–decorin coatings adsorbed on mica. Represented area 1 mm x 1
mm.
The presence of decorin, which promotes the entrapment of LDL particles to the ECM of the inner
layer of the arterial wall, modifies the collagen I and III structures [87,119]. The role of decorin in
fibrillogenesis and its effect on the adsorption patterns of collagens were investigated by premixing
decorin with dialyzed collagen solutions in the presence of NaCl before immobilization on fused
silica and mica surfaces. As shown in Figure 5, in almost all cases, the addition of decorin
decreased the fibril diameter resulting in thicker and more uniform collagen coatings being
immobilized on the substrate. Moreover, the films formed tightly packed and well-organized
fibrous networks. Surprisingly, the collagen III–decorin coating immobilized on fused silica was
aggregated, appearing as huge and irregular fibrils with low degree of coverage (Figure 5d).
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Although the reason for the aggregation is unknown, one explanation could be the difference in
hydrophobicity of the collagen III–decorin film and the fused silica substrate. Nevertheless, it is
clear that decorin, by promoting well-packed collagen fibrous networks with high degree of order,
stabilizes the collagen structures.
5.1.2 Thickness of collagen and collagen–decorin coatings
The thickness of the collagen coatings immobilized on fused silica and mica substrates, expressed
as full width at half maximum (FWHM), was calculated for the central peak in each AFM image
(Table 5). As expected, the thickness is related to the adsorption capability of the substrate. The
type I collagen coating immobilized on mica surface was much thinner (5.50 ± 0.97 ) than the
collagen I (7.72 ± 0.75 nm) and collagen III (7.05 ± 0.97 nm) coatings immobilized on fused silica
material. The mica substrate is much more hydrophilic than the fused silica substrate, so the more
hydrophilic collagen III adsorbed more easily than collagen I on the mica surface. As can be seen
in Table 5, the addition of decorin increased the thickness of the collagen coatings immobilized on
both the fused silica and mica substrates.
Table 5. The full width at half maximum for the central peak in individual AFM images of fused
silca and mica surfaces coated with collagens I and III without and with addition of decorin.
Material
FWHM [nm]
Collagen I Collagen I–decorin Collagen III Collagen III
Fused silica 7.72 ± 0.75 8.14 ± 0.86 7.05 ± 0.97 13.80 ± 1.62
Mica 5.50 ± 0.97 7.81 ± 0.43 8.10 ± 0.65 8.12 ± 1.08
5.1.3 Interactions between apolipoprotein B-100 peptide fragment and collagen surfaces
The QCM-based biosensor approach was employed to clarify the interactions between the positive
peptide residue apoB-100, which is responsible for the binding of LDL with proteoglycans
[120,121], and different collagen films immobilized on silicon dioxide sensor chip.
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Increasing concentrations of apoB-100 peptide fragment were introduced over various collagen
films to achieve sufficient data for the investigation of dissociation constant values. As shown in
Figure 6, the maximum frequency shift describing the binding of apoB-100 residue on the collagen
films is in all cases concentration dependent. Positively charged groups of the apoB-100 fragment
interact with the negatively charged groups of collagen through their arginine and lysine residues
[122]. In earlier work in the laboratory, the attachment of collagen I film to a carboxyl sensor chip
via amine coupling exposed several negative residues, providing binding sites for peptide residue
3359–3377 [6].
Figure 6. (I) Binding pattern of interaction between positive apolipoprotein B-100 peptide (3359–
3377) and a) collagen I, b) collagen III, and c) collagen I–decorin surfaces immobilized on silicon
dioxide sensor chip. (II) Corresponding Scatchard plots for equilibrium analysis of data at the end
of the association phase. Running conditions: flow rate, 25 mL/min; 25 oC, 20 mM BGE at pH 7.4
(phosphate buffer in the case of collagen I and collagen I–decorin, surfaces and HEPES in the case
of collagen III surface). ApoB-100 concentrations ranged from 20 to 60 mg/mL.
From Figures 6a-b and Table 6 we can see that the positive apoB-100 fragment interacted much
more  strongly  with  collagen  III  immobilized  on  silicon  dioxide  than  with  the  corresponding
collagen I film. Again, a possible explanation for the difference in binding patterns, as well as the
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dissociation constant values, is the difference in structure of collagens I and III. Type III is more
hydrophilic with more negative charges than type I, owing to the larger amount of hydroxyproline
groups [61]. The addition of decorin to the coating solutions made the collagen coatings more
negatively charged, resulting in stronger interactions with apoB-100 peptide. In the case of
collagen III–decorin film, the dissociation constant value could not be determined because of
aggregation and problems in regenerating the coated surface after introduction of the apoB-100
peptide residue. On the basis of the collagen aggregation apparent in the AFM image of the
collagen III–decorin coating (Figure 5d), it was assumed that the apoB-100 fragment adsorbed
very strongly on uncoated areas of the silicon dioxide surface.
Table 6. Calculated Kd values ± RSD% for interaction of positive apoB-100 peptide (3359–3377)
with silicon dioxide sensor chips coated with collagen and collagen–decorin.
Ligand Kd [mM]
Collagen I 8.9 ± 0.2
Collagen I-decorin 5.5 ± 0.1
Collagen III 5.4 ± 0.1
Collagen III-decorin very strong interaction
As can be seen in Figure 7, the binding patterns for interactions between positive apoB-100 peptide
fragment and collagen I, collagen III, and collagen I–decorin films are closely similar. The minor
differences in binding capacities can be attributed to variation in the surface preparation step. As
is  also  evident  from  Figure  7,  almost  no  or  very  slow  dissociation  occurs  for  the  collagen  III-
decorin coating, indicating that its interaction with the apoB-100 peptide fragment is stronger than
the interactions of the other films studied. Finally, the results show that the positive apoB-100
peptide residue has strong affinity to the major component of ECM (collagen) and that the affinity
is enhanced when decorin is associated with the collagen, as it is in the ECM.
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Figure 7. Comparison of binding patterns for interactions between positive apolipoprotein B-100
peptide (3359–3377) at concentration 20 mg/mL and (---) collagen I, (– . –) collagen III, (–)
collagen I–decorin, and (…) collagen III–decorin films immobilized on silicon dioxide sensor chip.
5.1.4 In situ glycation studies of collagen I on fused silica surface
Slow non-enzymatic reaction between glucose and proteins or lipoproteins in arterial wall is a
major mechanism for the development of atherosclerosis in diabetes [87]. Collagen, like other
long-lived proteins, can be glycated, giving rise to advanced glycation end products, formation of
cross-links, increased stiffness, resistance against enzymatic hydrolysis, and variability in the
affinity for plasma lipoproteins [89]. To clarify the effect of sugar on the collagen I structure, fused
silica capillary was coated with collagen solution and treated with D-glucose 6-phosphate for
selected intervals of time (8, 16, and 24 h). As is clear from the AFM images of Figure 8, glycation
caused the rearrangement of collagen, resulting in thinner fibrils with decreased density coverage.
Unmodified collagen I appeared as randomly distributed thick fibrils with a low degree of order,
while the glycated collagen fibrils were substantially decreased in thickness as the glycation
proceeded. Furthermore, after 24 h glycation, collagen fibrils formed an even, uniform coating,
and most probably cross-linking structure, as has been observed in other studies [88,123].
Although the resolution of the AFM images was too low to allow the cross-linkage of collagen
fibrils to be confirmed, it is nevertheless clear that the modification of collagen occurring during
glycation not only causes degradation of the hierarchical structure of the fibrils but also functional
disability.
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Figure 8. AFM images of a) unmodified collagen 1 coating immobilized on fused silica surface
and after glycation for b) 8 h, c) 16 h, and d) 24 h. Represented area 1 mm x 1 mm.
5.2 Studies on sugar treatment of lipoprotein particles
5.2.1 Separation of lipoprotein particles isolated by ultracentrifugation with different sugars
Separation of lipoprotein particles is a highly demanding task because of the heterogeneity of
lipoproteins and their undesired strong adsorption onto the fused silica capillary wall. In view of
findings reported in the literature [105,118], five sugars (monosaccharides, disaccharides, and
sugar alcohol) were tested for the preparative ultracentrifugation of lipoproteins. As expected, by
increasing the density of human plasma, sugar suppressed the adsorption of the particles onto the
capillary wall. Preliminary CE separation studies were done at ionic strengths of 5 and 20 mM of
BGE solution. Because of the lower electromigration dispersion, better separation efficiency and
resolution were achieved with the BGE of higher ionic strength, and this solution was selected for
use in the CE studies.
The combination of two fractions isolated in the presence of sorbitol was found to enable CE
separation of VLDL and IDL particles. The satisfactory separation of LDL and HDL, in turn, was
achieved when glucose was used in ultracentrifugation (Figure 9). Interestingly, the separation of
LDL and HDL was not achieved when either maltose with two glucose units or dextran
polysaccharide were employed in the isolation of lipoprotein particles. The results clearly
demonstrated that sugars not only shield the positive charges of apolipoproteins, diminishing their
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adsorption onto the fused silica capillary wall, but also affect the selectivity of lipoprotein
separations depending on their structure.
Figure 9. (A)  CE  separation  of  1)  VLDL  and  2)  IDL  at  200  nm  in  uncoated  capillary  after
ultracentrifugation of human lipoprotein particles with 20% m/m sorbitol solution. (B) CE
Separation  of  1)  LDL  and  2)  HDL  subclasses  at  200  nm  in  uncoated  capillary  after
ultracentrifugation of human lipoprotein particles treated with 20% m/m glucose solution. Running
conditions: +20 kV, injection for 2 s at 50 mbar, 25 oC, 20 mM phosphate buffer pH 7.4, Ltot 38.5
cm, Ldet 30 cm.
5.2.2 Effect of sugars on lipoprotein structures
AsFlFFF, DLS, and MD simulation studies were carried out to support and complement the results
obtained by CE.
AsFlFFF and DLS were employed to measure the size of native LDL and HDL particles isolated
from human plasma during ultracentrifugation in the presence of sugars. The results indicated that
sugars reduce the size of the lipoprotein structure (Table 7). However, although the effect was
observed for both LDL and HDL, it was stronger for HDL particles, probably due to differences
in the structural composition of the lipoproteins, and especially to the heterogeneity of the HDL
particles. Further, the AsFlFFF results showed the lipoprotein–sugar profile to depend on the type
of sugar used in the ultracentrifugation process (Figure 10).
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Table 7. Effect of sugars on the size of lipoprotein particles measured by AsFlFFF and DLS.
Sample Particle diameter [nm] Sample Particle diameter [nm]
FFF DLS FFF DLS
LDL-sucrose 22.70 ± 0.39 18.54 ± 0.45 HDL-sucrose 7.31 ± 0.71 9.50 ± 1.06
LDL-maltose 22.38 ± 0.77 18.07 ± 0.37 HDL-maltose 7.93 ± 0.21 9.00 ±  0.92
LDL-sorbitol 22.32 ± 0.22 18.21 ± 0.14 HDL-sorbitol 7.93 ± 0.69 9.64 ± 0.88
LDL-fructose 22.87 ± 1.00 19.29 ± 0.51 HDL-fructose 8.94 ± 0.14 8.70 ± 0.50
LDL-glucose 22.67 ± 0.67 19.20 ± 0.78 HDL-glucose 9.52 ± 0.24 9.65 ± 0.54
native LDL 23.27 ± 0.32 22.73 ± 0.29 native HDL2 10.55 ± 0.10 10.88 ± 0.59
Although both techniques confirmed the shrinkage of lipoprotein particles when treated with
sugars,  the  absolute  sizes  were  slightly  different.  As  is  well  known,  DLS  is  more  sensitive  to
sample aggregation, which may lead to overestimation of the size distribution.
Figure 10. Particle  size  distributions  of  A)  LDL  and  B)  HDL  fractions  isolated  by
ultracentrifugation in the presence of 20% m/m sugar solutions, measured by AsFlFFF. Running
conditions: 9.0 mM phosphate buffer (pH 7.4) containing 140 mM NaCl. Relaxation focusing,
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flow rate at inlet 0.15 ml min−1, flow inward from outlet 1.5 ml min−1, injection volumes 300-500
µl, relaxation time 11 min. Flow rates during elution, Vout 0.50 ml min−1 and Vcout 2.50 ml min−1.
Detection at 280 nm.
MD simulations were applied to examine the effect of sugars on structures of the apoB-100 peptide
fragment, the major protein of LDL, and the apoE peptide fragment, one of the most important
proteins of HDL particles. The results demonstrated the shrinkage of both apolipoproteins in the
presence of sugars, confirming the results obtained by AsFlFFF and DLS. However, even though
the effect was observed for both apolipoproteins, it was stronger for the apoB-100 peptide fragment
(Figure 11). The findings suggest that, in addition to the studied apolipoprotein peptide fragments,
other fragments and the overall lipid composition of the lipoprotein particles contribute to the
interactions with sugars.
Figure 11. Apolipoprotein B-100 peptide fragment in the absence and presence of maltose.
5.3 Development of polycationic coating for the separation studies
Surface-initiated atom transfer radical polymerization (SI-ATRP), a versatile method to anchor
polymers covalently on substrates, was accordingly tested as a means to obtain a stable covalently
57
bound coating on the fused silica capillary wall. MOTAC solution, a strong and positively charged
electrolyte over the whole pH range, was employed as starting reagent to achieve a stable
PMOTAC coating that would suppress EOF and diminish the adsorption of positively charged
analytes.
5.3.1 Optimization of PMOTAC coating procedure
The coating procedure comprised three steps: pretreatment, silanization, and polymerization.
Preliminary experiments showed that the capillary was frequently blocked due to precipitation of
the triethylamine hydrochloric acid salt that formed during the reaction. To enable the silanization,
we decreased the concentration of the silanization reagent, and in addition flushed the pretreated
capillary periodically, first with the silanization reagent and then with trimethylamine–methanol
solution. Moreover, purging of nitrogen during the silanization and polymerization steps was
found to be essential for successful coating of the capillary.
Each reaction step was monitored by recording FT-IR spectra (figure presented in Paper IV). The
unmodified fused silica capillary showed strong peaks at 1098 cm-1 and 805 cm-1 originating from
the SiO2 surface. After the silanization step, –CH2– groups showed weak absorptions at 2922 cm-
1 and 2852 cm-1. Finally, the polymerized fused silica surface gave a strong absorption peak due to
–CH2– groups in the range from 2957 cm-1 to 2858 cm-1. As well, a strong carbonyl signal appeared
at 1727 cm-1. In all cases, strong absorption peaks referring to the SiO2 surface were seen as well.
The FT-IR spectra confirmed the successful establishment of the coating.
5.3.2 Stability and reproducibility of PMOTAC coating
To be applicable for separation studies, the PMOTAC coating needs to exhibit high reproducibility
and good stability over the whole pH range. In this study, EOF was measured in the pH range 3–
8. The results showed almost constant EOF values at pH 3–5 with RSD values between 0.1% and
1.0%. At higher pH, the anodic EOF decreased, evidently owing the decrease in the net charge of
the PMOTAC coating caused by the electrostatic interaction between BGE counter ions and the
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coating. This hypothesis was confirmed by light scattering measurement of the hydrodynamic
dimensions of the free PMOTAC chain at all pH values studied (data presented in Paper IV).
The PMOTAC-coated capillary was characterized with DMSO used as EOF marker. The RSD
value for run-to-run repeatability in six successive runs was as low as 0.2%; capillary-to-capillary
reproducibility measured for five different capillaries was 1%; and day-to-day reproducibility
measured  for  15  days  was  4%  at  pH  4  with  ionic  strength  of  20  mM.  Moreover,  the  capillary
coating was stable during one month with RSD value of 0.5% for 25 successive runs. The stability
of the PMOTAC-coated capillaries was excellent and the separations of model compounds were
achieved.
5.3.3 Separation of proteins, b-blockers and lipoproteins
The excellent stability and the biofouling properties of the PMOTAC-coated capillaries were
verified in the bioseparation of complex samples of basic proteins, b-blockers, and lipoprotein
particles with different molar mass ranges. The separation conditions were optimized for each
group of model analytes in pH range 3–5, where the coating was known to be very stable.
The most efficient separation of basic proteins (a-chymotrypsinogen A, cytochrome c, and
lysozyme) was achieved at pH 5, I 20  mM.  The  repeatability  of  the  migration  times,  the
reproducibility capillary-to-capillary, the separation efficiency in terms of theoretical plate
numbers, and the recoveries of the basic proteins were then evaluated under the conditions of the
most efficient separation (Table 8).
Table 8. RSD values for the migration times, theoretical plate numbers, reproducibility capillary-
to-capillary, and recoveries of three basic proteins at pH 5, I 20 mM.
Analyte tm[%RSD]
N
[1/m]
Reproducibility
capillary-to-capillary
[%RSD]
Recovery
[%]
Lysozyme 0.3 132000 0.8 93.2
a-Chymotrypsinogen 0.6 261000 1.4 95.3
Cytochrome C 0.5 303000 1.0 97.8
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As already pointed out, the heterogeneity of lipoprotein particles and their unwanted adsorption
onto the fused silica capillary wall places great demands on their separation [117]. With cationic
PMOTAC coating, the satisfactory separation of lipoprotein particles HDL (pI 5.0) and LDL (pI
5.5) was achieved at pH 3 and 4. The particles exhibit net positive charges in pH range 3–5 (Figure
12) [30,32].
Figure 12. Separation of 1) HDL and 2) LDL in uncoated capillary (a), in PMOTAC-coated
capillary at pH 3, I 20 mM (b), and in PMOTAC-coated capillary at pH 4 I 20 mM (c). Running
conditions: -12 kV, injection for 2 s at 50 mbar, 25 oC, Ltot 38.5 cm, Ldet 30 cm, UV detection 214
nm, and lipoprotein concentrations 0.5 mg/mL for each lipoprotein.
Surprisingly, the larger LDL migrated before HDL at pH 3, but the elution order was the reverse
at less acidic pH 4. The difference in the migration order might be due to the difference in
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composition of the BGE solutions at  pH 3 and pH 4 (phosphate and acetate,  respectively).  The
difference in composition might affect the net charges of the analytes as well as the conformation
of the PMOTAC chains attached to the fused silica capillary wall. The best separation was obtained
at pH 3, I 20 mM at -12kV. The results confirmed that the PMOTAC coating successfully
eliminates the adsorption of positively charged analytes onto the inner fused silica capillary wall.
5.4 Interaction studies on apolipoprotein E isoforms
Although PMOTAC-coated capillaries offered stable and reliable platforms for the clinical
screening experiments and for the separation of small molecules, the separation of lipoprotein
particles was not satisfactory. In addition, the PMOTAC coating proved unsuitable at
physiological pH 7.4, which is the required pH for interaction studies on lipoproteins. As a means
to overcome these problems, the neutral diblock copolymer coating with hydrophilic properties
recently developed in our laboratory was tested for the interaction studies [12, 114].
5.4.1 Establishment of neutral diblock copolymer coating
The silanol groups of the fused silica capillary were effectively shielded with the P2QVP-b-PEO
diblock copolymer coating [114]. The positively charged P2QVP block was attached to the
negatively charged inner wall of the capillary, while the neutral hydrophilic PEO block formed the
stable neutral surface. EOF mobilities measured by the Williams and Vigh method confirmed that
a neutral coating was successfully established. EOF mobilities were effectively suppressed in the
range 1.0×10-10 to 7.3×10-10 m2/Vs at pH 7.4, indicating the slightly cationic nature of the capillary.
This resulted in very slow anodic EOF.
5.4.2 Interactions of apolipoprotein E isoforms with chondroitin-6-sulfate
The binding of apoE, an exchangeable apolipoprotein constituent of VLDL and HDL particles, to
GAGs in the arterial intima plays an important role in the development of atherosclerosis. The PF-
ACE–AED approach was applied to investigate the interactions between C6S and the main apoE
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isoforms (apoE2, apoE3, and apoE4) and apoE-containing HDL2. First, the biomolecular
interactions were evaluated by PF-ACE at 25 oC with 20 mM phosphate buffer at pH 7.4. Next,
values of affinity constants were determined by the three-step procedure described in section 4.2.6.
In PF-ACE studies, the neutral capillary was first filled either with isoforms of apoE or with apo-
containing HDL2 and then C6S was introduced. All analytes were negatively charged so that, after
the voltage was applied, they began to move toward the anode, which was acting as a detector.
Because of the slightly cationic nature of the P2QVP-b-PEO coating, C6S migrated faster than the
isoforms of apoE and apoE-containing HDL2 and was able to interact with them (Figures 13-15).
Data corresponding to the interaction between apoE-containing HDL2 and  C6S  have  been
published as supporting information of Paper V.
Figure 13. Electropherograms obtained by affinity capillary electrophoresis with partial filling
technique are presented as a function of increasing concentrations of C6S in interaction with
apoE2. Running conditions: -25 kV, injection time of isoforms of apoE 2 s at 50 mbar, injection
time of C6S 3 s at 50 mbar, 25 oC, Ltot 38.5 cm, Ldet 30 cm, UV detection 200 nm, BGE phosphate
buffer (pH 7.4, I 20mM), apoE2 concentration 0.2 mg/mL, and C6S concentration ranging from
0.003 mg/mL to 1.0 mg/mL.
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Figure 14. Electropherograms obtained by affinity capillary electrophoresis with partial filling
technique are presented as a function of increasing concentrations of C6S in interaction with
apoE3. Running conditions: -25 kV, injection time of isoforms of apoE 2 s at 50 mbar, injection
time of C6S 3 s at 50 mbar, 25 oC, Ltot 38.5 cm, Ldet 30 cm, UV detection 200 nm, BGE phosphate
buffer (pH 7.4, I 20mM), apoE3 concentration 0.2 mg/mL, and C6S concentration ranging from
0.003 mg/mL to 1.0 mg/mL.
The  migration  time  of  the  excess  of  C6S  remained  constant,  while  the  migration  times  of  the
formed complexes decreased as the amount of negatively charged C6S increased. The absolute
values of the apoE isoform mobilities decreased based on their number of charged amino acid
residues,  i.e.  apoE2 > apoE3 > apoE4. Even though, the changes for apoE2 isoform and apoE-
containing HDL2 were minor, data obtained could be still examined by AED calculations.
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Figure 15. Electropherograms obtained by affinity capillary electrophoresis with partial filling
technique are presented as a function of increasing concentrations of C6S in interaction with
apoE4. Running conditions: -25 kV, injection time of isoforms of apoE 2 s at 50 mbar, injection
time of C6S 3 s at 50 mbar, 25 oC, Ltot 38.5 cm, Ldet 30 cm, UV detection 200 nm, BGE phosphate
buffer (pH 7.4, I 20mM), apoE4 concentration 0.2 mg/mL, and C6S concentration ranging from
0.003 mg/mL to 1.0 mg/mL.
The AED analysis clearly revealed the heterogeneity in the C6S interactions with the isoforms of
apoE and apoE-containing HDL2. As shown in Figures 16-18, the binding was a homogeneous
adsorption process in the apoE3–C6S and apoE-containing HDL2–C6S systems, while in the
apoE2–C6S and apoE4–C6S systems it was heterogeneous with two different adsorption sites.
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Figure 16.  (A) Adsorption isotherm of apoE2, (B) corresponding Scatchard plot,  and (C) AED
calculations for the apoE2–C6S system at 25 oC.
Figure 17. (A) Adsorption isotherm of apoE3, (B) corresponding Scatchard plot,  and (C) AED
calculations for the apoE3–C6S system at 25 oC.
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Figure 18. (A) Adsorption isotherm of apoE4, (B) corresponding Scatchard plot,  and (C) AED
calculations for the apoE4–C6S system at 25 oC.
The association equilibrium constant values were determined and expressed as logKa (Table 9).
The results allowed evaluation of the binding strength with C6S, providing the following order:
apoE-containing HDL2 > apoE2 > apoE4 > apoE3. As can be seen, apoE-containing HDL2 had the
strongest interaction with C6S and apoE3 the weakest. Note, however, that the amount and type
of isoform(s) in the HDL2 sample was unknown. Moreover, the binding strength may be modulated
by other HDL surface components located near apoE. The differences in affinity constant values
could be due to the differences in the structural composition of the apoE isoforms. The tertiary
structure of the apoE isoforms has a significant impact on the assessment of the interaction
strength. ApoE consists of two domains (N- and C-terminals) separated by a hinge region. The N-
terminal domain (amino acids 1–191) includes the receptor-binding region (amino acids 134–150;
Arg-172) and appears as a four-helix antiparallel bundle, whereas the C-terminal (amino acids
225–299) contains the major lipid (especially phospholipid)-binding region (amino acids 244–272)
[124,125]. However, the several isoforms of apoE differ in their amino acid sequences: apoE3
contains cysteine as the 112th amino acid and arginine as the 158th, while apoE4 has arginines at
both sites and apoE3 has cysteines. The presence of cysteine helps to stabilize the secondary and
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tertiary protein structures through the formation of disulfide bonds. Arginine, in turn, improves the
affinity by interacting with negatively charged GAGs. The mutation from arginine to cysteine
group may enhance or abolish the interactions with C6S according to the alteration of accessible
adsorption sites.
Table 9. Affinity constants (logKa) with the model fit values (R2) for the interactions between GAG
chains of PGs and isoforms of apoE and apoE-containing HDL2.
Analytes Model fits
ApoE2
0.957
ApoE3
0.959
ApoE4
0.973
ApoE-containing HDL2
0.870
C6S (I)  6.9(II) 6.0 (I)  6.0
(I) 6.8
(II) 5.7 (I) 7.3
DS (I)  6.1 (I)  5.9(II) 4.8
Further relevant to the binding order could be the structural properties. ApoE4 shows a domain
interaction promoted by the arginine in position 112 and by the formation of a salt-bridge between
Arg61 and Glu255, which supports its tertiary structure. Moreover, apoE4 is susceptible to
unfolding, and changes in temperature can affect its structure so that it takes on a different shape.
Both apoE2 and apoE3 tend to be more stable and have fewer or no domain interactions, so that
they assume more open structures. The domain interactions are promoted by the close proximity
of the N- and C-terminals containing the GAG binding sites and thus may enhance the strength of
interactions. This may explain the stronger interaction of apoE4 than of apoE3.
5.4.3 Interactions of apolipoprotein E isoforms with chondroitin-6-sulfate and dermatan
sulfate
Affinity constant values were compared for the interactions between apoE isoforms and C6S and
DS,  the  important  GAG  chains  of  PGs  [12].  As  can  be  seen  in  Table  9,  interactions  of  apoE
isoforms  with  C6S  are  slightly  stronger  than  the  interactions  of  the  apoE  isoforms  with  DS.
Interestingly, the heterogeneity of the interactions of apoE isoforms is different for the two GAGs,
i.e., heterogeneous binding with two adsorption sites was revealed for apoE3–DS interaction,
while the homogeneous (one site) adsorption process was observed for apoE3–C6S interaction.
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The reverse behavior was observed for the apoE2 isoform, which showed two-site binding with
C6S and one-site binding with DS. The difference in affinity can be attributed to the structural
differences of the GAGs. Both have a long charged polysaccharide chain but the chains contain
different amounts of iduronic acid [98]. Iduronic acid affects the properties of the polysaccharides
by generating a more flexible chain with high binding potential and allowing specific interactions
with proteins.
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6 Conclusions
The aim of this doctoral work was to develop miniaturized analytical tools suitable for
investigating the biomolecular interactions that occur in the ECM and demonstrate the significance
of these interactions for atherogenesis and diabetes. Several experimental techniques were applied
for studies on the separation and interactions of major ECM components, lipoprotein particles, and
the sugar-modified counterparts of these.
Collagen, a major constituent of ECM, is implicated in the development of atherosclerosis and
diabetes. AFM was used to examine the structural and molecular properties of collagens I and III
by immobilizing the collagens on fused silica capillary and mica surfaces under physiological
conditions. Decorin, which promotes the binding of lipoprotein particles with collagen, was
investigated for its effect on the fibrillogenesis. The addition of decorin was found to reduce the
diameter of collagen fibrils and particularly affect the collagen films, which became more uniform
and even. Fibril formation varied significantly with the substrate and type of collagen.
Furthermore, in situ glycation of collagen I immobilized on the fused silica capillary surface
resulted in thinner collagen fibrils and decreased density coverage of the surface. In addition to
AFM, the QCM measurements played an important role in the studies by providing the
characteristics of interactions between the same immobilized collagen films and apoB-100 peptide
residue. The results confirmed expectations, i.e., bindings take place between the positively
charged residues (lysine and arginine) of apoB-100 and negative charges of collagens.
CE was utilized to study the separation of lipoprotein particles modified with different sugars.
Monosaccharides, disaccharides, and one sugar alcohol used during the isolation of lipoproteins
prevented the strong and unwanted adsorption of lipoprotein particles on the inner wall of the fused
silica capillary, allowing their separation in uncoated capillary at physiological pH 7.4. Neither
permanent nor dynamic coating of the capillary was required. In addition, the sugars affected the
selectivity of the separation by shielding the positive charges of the apolipoproteins. Interestingly,
AsFlFFF and DLS measurements showed the sugars to decrease the particle size of the HDL and
LDL, a finding supported by the MD simulations. MD studies indicated that not only the peptide
69
residues investigated but also other fragments of apolipoproteins may contribute to the interaction
of lipoproteins with sugars.
A covalent polycationic coating, applied in an on-line three-step polymerization procedure, was
successfully developed for the separation of small proteins, b-blockers, and lipoproteins. The
platform demonstrated good stability in the pH range of 3–5, as well as long-term stability, and
good repeatability and reproducibility.
PF-ACE was used for determination of the strong and weak interactions between the most common
isoforms of apoE of HDL and the main GAG chain of PGs, C6S. The PF-ACE technique enables
fast evaluation of affinity constants only for single-type interactions, however, and the
heterogeneity of interactions was investigated with AED calculations. The results revealed clear
differences in the interactions. Thus, the interactions of apoE2 apoE4 isoforms were
heterogeneous, with two different adsorption sites, while, surprisingly, for apoE3 and apoE-
containing HDL2,  the  binding  was  homogeneous,  with  one  adsorption  site.  Integration  of  AED
calculations with the PF-ACE technique provided an excellent and powerful tool for the
clarification of such small  changes in interactions as those due to the mutation of single amino
acid.
All the methods developed in this study share some significant features. They are suitable for
separation and interaction studies on biomolecules and they are easy to conduct and relatively
inexpensive thanks to the small consumptions of sample and reagent. Most importantly, they can
be exploited for a deeper understanding of biological processes that appear in the ECM and
demonstrate the relationship of these processes to diseases, most notably atherogenesis and
diabetes.
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